Form 4 for CI Cigna
Accepted 2022-02-25 00:00:00 ET · period of report 2022-02-23 · accession 0001225208-22-003487 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-25 | 2022-02-23 | CI | Neville Everett | EVP, Strategy, Business Dev | A - Grant | $0.00 | +2,423 | 8,221 | +42% | $0 |
| D | 2022-02-25 | 2022-02-23 | CI | Neville Everett | EVP, Strategy, Business Dev | A - Grant | $0.00 | +10.9K | 10.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $.01 Par Value | 2022-02-23 | A | A | 2,423 | $0.00 | 8,221 | D | — | — | (F1) These restricted shares vest in three equal annual installments beginning March 1, 2023. |
| 2 | Derivative | Employee Stock Option (Right to Buy) | 2022-02-23 | A | A | 10,865 | $0.00 | 10,865 | D | $227.02 · 2023-03-01 to 2032-02-23 | 10,865 Common Stock, $.01 Par Value | (F2) This option vests in three equal annual installments beginning March 1, 2023. |